NeuroSense Therapeutics, Ltd. - Multiplikator nilai perusahaan marang pendapatan NRSN

Logo perusahaan publik NeuroSense Therapeutics Ltd (NRSN)

NeuroSense Therapeutics (NRSN) develops treatments for ALS and Alzheimer's disease through partnerships with global clinics. This EV/Revenue chart confirms the current trend, where the value of 0.00 expresses the metric level. High molecule testing costs and the risk of failure create a steep barrier to entry. Currently, the company is systematically deploying capital toward R&D in the absence of operating income.

NeuroSense Therapeutics, Ltd. - Nilai perusahaan marang pendapatan NRSN (periode 23.11.2025 - 20.11.2026)

NeuroSense Therapeutics, Ltd. - rincian analitis lan metrik utama (NRSN)

Analisis wiwitan perusahaan:NeuroSense Therapeutics Ltd NRSN
Sampel barang NeuroSense Therapeutics Ltd

The market value of NeuroSense Therapeutics (NRSN) within the context of ALS therapy development reflects investor expectations regarding long-term patent control over the drug lifecycle. By analyzing the EV/Sales multiple, you can observe the ratio of enterprise value (market capitalization plus net debt) to revenue, which allows for an assessment of the real price of one dollar of sales without debt load distortions to determine investment attractiveness.

Analisis pesaing NeuroSense Therapeutics

BIIB (Biogen Inc.) - Rasio nilai perusahaan marang pendapatan|NBIX: Multiplikator EV/Sales|RGC (Regencell Bioscience Holdings Limited) - Rasio nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan Axsome Therapeutics Inc|ACAD: Nilai bisnis marang pendapatan|Multiplikator EV/Sales XENE|Multiplikator EV/Sales vikingtherapeutics.com (VKTX)|Rasio nilai perusahaan marang pendapatan Supernus SUPN|Nilai bisnis marang pendapatan CPRX|denalitherapeutics.com - Multiplikator EV/Sales|Rasio total nilai perusahaan marang pendapatan Harmony Pharma HRMY|BHVN: Multiplikator EV/Sales|Multiplikator nilai perusahaan marang pendapatan Amylyx Pharmaceuticals, Inc. (AMLX)|TRVI (Trevi Therapeutics Inc) - Multiplikator EV/Sales|Rasio nilai perusahaan marang pendapatan PRAX (Praxis Medicines)|Rasio nilai perusahaan marang pendapatan Anavex Life Sciences (AVXL)|Rasio nilai perusahaan marang pendapatan CBLL (CeriBell EEG)|Multiplikator EV/Sales PRTA (Prothena Corp)|alector.com (ALEC) - Multiplikator nilai perusahaan marang pendapatan|ANNX: Nilai perusahaan marang pendapatan|Multiplikator nilai perusahaan marang pendapatan Omeros|NGNE: Multiplikator EV/Sales|Nilai perusahaan marang pendapatan AC Immune|Nilai perusahaan marang pendapatan VYGR|Rasio nilai perusahaan marang pendapatan NMRA (neumoratx.com)|Nilai perusahaan marang pendapatan SCLX (Scilex Holding Company, Inc.)|Rasio nilai perusahaan marang pendapatan TVGN (Tevogen Bio)|Rasio nilai perusahaan marang pendapatan Alpha Cognition ACOG|CGTX - Nilai perusahaan marang pendapatan|IKT - Rasio nilai perusahaan marang pendapatan|SAVA: Rasio nilai perusahaan marang pendapatan|Assertio Therapeutics (ASRT) - Rasio nilai perusahaan marang pendapatan|Multiplikator nilai perusahaan marang pendapatan Coya Therapeutics Inc (COYA)|Rasio nilai perusahaan marang pendapatan Vistagen|Rasio nilai perusahaan marang pendapatan OVID (ovidrx.com)|Rasio nilai perusahaan marang pendapatan Acumen Pharmaceuticals, Inc. (ABOS)|CRVO - Multiplikator nilai perusahaan marang pendapatan|Alterity Therapeutics Ltd. - Nilai perusahaan marang pendapatan|CLNN - Nilai perusahaan marang pendapatan|PEPG - Rasio nilai perusahaan marang pendapatan|Rasio total nilai perusahaan marang pendapatan jupiterneurosciences.com JUNS|Relmada Therapeutics (RLMD) - Rasio nilai perusahaan marang pendapatan|ANVS (Annovis Bio, Inc.) - Rasio nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan gracetx.com|Multiplikator EV/Sales Firefly Neuroscience, Inc.|Rasio nilai perusahaan marang pendapatan ANEW Medical (KLTO)|RVPH (Reviva Pharmaceuticals Holdings) - Nilai bisnis marang pendapatan|MetaVia - Nilai perusahaan marang pendapatan|NRXS: Rasio nilai perusahaan marang pendapatan|Helius Medical Technologies, Inc. - Multiplikator EV/Sales|PASG: Rasio nilai perusahaan marang pendapatan|Neuphoria (NEUP) - Rasio nilai perusahaan marang pendapatan|Minerva Neurosciences - Nilai bisnis marang pendapatan|ATHA (Athira Pharma, Inc.) - Multiplikator EV/Sales|Multiplikator nilai perusahaan marang pendapatan addextherapeutics.com ADXN|Nilai perusahaan marang pendapatan ALZN (Alzamend Neuro Inc.)|CYCN (Cyclerion Therapeutics, Inc.) - Nilai bisnis marang pendapatan|Multiplikator EV/Sales PTIX (Protagenic)|Multiplikator EV/Sales pasitheaclinics.com KTTA|CRGT - Rasio nilai perusahaan marang pendapatan|Nilai bisnis marang pendapatan ATXI (Avenue Therapeutics)|BCLI: Multiplikator EV/Sales|Cara Therapeutics - Nilai bisnis marang pendapatan|Rasio nilai perusahaan marang pendapatan Chromocell Therapeutics Corporation|Multiplikator EV/Sales Eliem Therapeutics Inc.|Rasio nilai perusahaan marang pendapatan Intra-Cellular Therapies, Inc. (ITCI)|LBPH (Longboard Pharmaceuticals) - Nilai bisnis marang pendapatan|Multiplikator EV/Sales MRNS (marinuspharma.com)|NKGN: Rasio nilai perusahaan marang pendapatan|NRBO - Rasio nilai perusahaan marang pendapatan|SAGE - Multiplikator EV/Sales|Synaptogenix (SNPX) - Rasio nilai perusahaan marang pendapatan|Multiplikator nilai perusahaan marang pendapatan Trevena (TRVN)|Nilai perusahaan marang pendapatan VIGL|Rasio nilai perusahaan marang pendapatan WENA (Anew Medical)|Multiplikator EV/Sales CERE